Androutsou, M.-E.; Nteli, A.; Gkika, A.; Avloniti, M.; Dagkonaki, A.; Probert, L.; Tselios, T.; Golič Grdadolnik, S.
Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis. Int. J. Mol. Sci. 2020, 21, 7566.
https://doi.org/10.3390/ijms21207566
AMA Style
Androutsou M-E, Nteli A, Gkika A, Avloniti M, Dagkonaki A, Probert L, Tselios T, Golič Grdadolnik S.
Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis. International Journal of Molecular Sciences. 2020; 21(20):7566.
https://doi.org/10.3390/ijms21207566
Chicago/Turabian Style
Androutsou, Maria-Eleni, Agathi Nteli, Areti Gkika, Maria Avloniti, Anastasia Dagkonaki, Lesley Probert, Theodore Tselios, and Simona Golič Grdadolnik.
2020. "Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis" International Journal of Molecular Sciences 21, no. 20: 7566.
https://doi.org/10.3390/ijms21207566
APA Style
Androutsou, M.-E., Nteli, A., Gkika, A., Avloniti, M., Dagkonaki, A., Probert, L., Tselios, T., & Golič Grdadolnik, S.
(2020). Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis. International Journal of Molecular Sciences, 21(20), 7566.
https://doi.org/10.3390/ijms21207566